Therapeutic method for treating blood-clotting defects with factor VIIa
US4382083A · kind A · utility
36Cited by
2References
19Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 25, 1981 |
| Grant date | May 3, 1983 |
| Priority date | — |
| Expiry date | Jun 25, 2001 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/4846
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Patients having a clotting factor defect can be successfully treated by the administration of a composition containing effective hemostatic amounts of factor VIIa. Preferably, the factor VIIa is substantially free of factors IXa and Xa. Procedures for preparing the above therapeutic compositions are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.